Amount Raised
$60 Million
Round Type
series a
Description
Colossal Biosciences, a biosciences and genetic engineering company, has raised $60 million in Series A financing.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech